Rare diseases
Investigational molecules
Locations
Ul. Fryderyka Szopena 1, 35-055 Rzeszow, Poland
Centrum Medyczne Medyk Sp. z o.o. in Rzeszow, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Multiple sclerosis, Obesity, and other specialisations. This site conducts important research.
The site focuses on Neoplasms, specifically on hormone receptor‑positive and HER2‑negative locally advanced, unresectable or metastatic breast cancer. Current studies aim to test innovative combination regimens that pair an AKT pathway inhibitor with CDK4/6 inhibitors and endocrine therapy to improve patient outcomes.
With a team of 13 investigators, Centrum Medyczne Medyk in Rzeszow is contributing valuable data to advance treatment options for this breast cancer subtype.
In the area of Digestive System Diseases, the centre conducts trials on ulcerative colitis, evaluating new therapeutic agents designed to induce remission in patients with moderate to severe disease activity. The research seeks to enhance disease control while monitoring safety and patient‑reported outcomes.
The ongoing work at Centrum Medyczne Medyk reflects a commitment to improving care for individuals living with inflammatory bowel conditions.
Clinical trials currently enrolling participants at this site.
PolandLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
PolandA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
PolandStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
PolandStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
